Evolution of USP<1058> updates and insights in regulations

By watching this presentation you will learn about:

  • How USP <1058> aligns with GAMP® 5
  • Core elements of the <1058> instrument life-cycle framework
  • Areas of <1058> the USP are exploring improvements in

Event overview

The United States Pharmacopeia (USP) is the only major pharmacopeia with a general chapter dedicated to analytical instrument qualification (USP <1058>). This makes <1058> a globally significant regulatory reference. However, despite the significant changes with the 2017 edition of <1058>, 68% of laboratories have not updated their qualification procedures. Additionally, the USP has already started the process to initiate updates to <1058>, when many laboratories may not fully comply with the current edition!

This raises many questions about the role of the current <1058> general chapter and how it aligns with the recently issued 2nd Edition of GAMP® 5.

What you need to know:

Format: On-demand

Duration: Approximately 1 hour


PaulSmith_200Paul Smith
Global Laboratory Compliance Marketing Specialist (USP <1058>),
Agilent Technologies, Inc.

Paul has a passion for laboratory compliance and started his career as an Infrared Spectroscopist, performing his first FT-IR software validation in 1992, 30 years ago. In his current Agilent role, Paul is an active member of GAMP, a member of the UK GAMP Community of Practice (CoP) steering committee and has contributed to GAMP® Good Practice Guides. He helps laboratories understand their laboratory instrument qualification requirements and writes publications and white papers about this.




Registrants to this webinar are covered by the Eclipse Business Media Ltd Privacy Policy. Information you provide will be shared with the sponsors for this content. Eclipse Business Media Ltd may contact you to offer you content based on your specific interests. You may opt-out at any time.